問卷

TPIDB > Principal Investigator

Principal Investigator


Taipei Veterans General Hospital (在職)

Division of Cardiovascular Diseases

Shin Kong Memorial Wu Ho-Su Hospital

Division of Cardiovascular Diseases

更新時間:2023-09-19

常敏之Charng, Min-Ji
  • Principal Investigator
  • Clinical Trial Experience (year) 23 years 9 個月
  • iceland930@gmail.com

篩選

List

37Cases

2019-05-02 - 2026-01-17

Phase III

A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Impact of Evolocumab on Major Cardiovascular Events in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
  • Condition/Disease

    Coronary Heart Disease (CHD)

  • Test Drug

    Repatha

Participate Sites
10Sites

Recruiting9Sites

Terminated1Sites

2016-03-24 - 2019-12-28

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2019-01-01 - 2021-08-30

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
2Sites

Terminated2Sites

2019-02-06 - 2021-09-09

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

2018-02-15 - 2019-07-16

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

常敏之
Taipei Veterans General Hospital

Division of Cardiovascular Diseases

2021-02-01 - 2023-11-16

Others

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Not yet recruiting1Sites

2019-03-01 - 2021-07-31

Phase III

  • Condition/Disease

  • Test Drug

Participate Sites
1Sites

Terminated1Sites

常敏之
Taipei Veterans General Hospital

Division of Cardiovascular Diseases

1 2 3 4